Solid IO Alternatives & Competitors
12 companies similar to Solid IO — ENDING THE GUESSWORK IN CANCER CARE | Patient-specific organ-on-chip technology...
Companies similar to Solid IO
VitroScan
Predictive Testing Solutions
Leiden, The Netherlands
Scailyte
True precision medicine through single-cell science.
Basel, Switzerland
OncoPrecision
Leveraging single-cell high-throughput biology and AI/ML to dramatically increase the succ...
New York, United States
Epitopea
Exploiting a new class of tumour specific antigens for cancer therapy
Montreal, Canada
Rival Readout
Competing with Solid IO? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Cytimmune Sciences
Developing safer more effective therapies that can attack tumors on multiple fronts simult...
Rockville, United States
TransCode Therapeutics, Inc.
Delivering a cancer-free future
Newton, United States
Fresh Wind Biotechnologies
Transforming cancer therapeutics with cutting-edge immunotherapy
Houston, United States
Treadwell Therapeutics, Inc.
The Path to Better
New York, United States
iOnctura
Developing precision small molecules to combat hard-to-treat tumors.
Geneve, Switzerland
Ankyra Therapeutics
Developing cancer therapies based on localized cytokines that prime a systemic adaptive im...
London, United Kingdom
About Solid IO
Solid IO, founded in 2025 and headquartered in Finland, is pioneering advancements in precision oncology and immunotherapy through its unique organ-on-chip technology. The company's slogan, "ENDING THE GUESSWORK IN CANCER CARE," underscores its commitment to providing patient-specific data that empowers stakeholders in...
Tumor-on-chip platform, Patient-specific treatment insights, Immunotherapy research support, Early-stage clinical trial facilitation
Pharmaceutical Companies, Biotech Firms, Cancer Clinics, Oncologists, Researchers
Organ-on-chip Technology, Precision Oncology, Immunotherapy, Tumor Microenvironment, Clinical Trials Optimization, Drug Development Acceleration, Biomarker Validation, Personalized Immunotherapies, Cancer Research, Patient-specific Treatment, Oncology Data Insights, Pharmaceutical Innovation, Biotech Collaboration, Precision Medicine
B2B, SaaS, Platform
Licensing, Service Fee, Usage Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Solid IO: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Solid IO on 13 Nov 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 29 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
